Literature DB >> 5762044

The pharmacological properties of fibrinogen degradation products.

K Buluk, M Malofiejew.   

Abstract

1. A method of obtaining partially purified products of plasmin degradation of fibrinogen (F.D.P.) is described. The F.D.P. passes through dialysing tubes and does not lose its activity during heating for 15 min at a temperature of 56 degrees C.2. In experiments on isolated organs, F.D.P. in small doses potentiates the contractile action of bradykinin, kallidin, angiotensin, histamine, 5-hydroxy-tryptamine, acetylcholine, adrenaline and noradrenaline. In high concentrations, F.D.P. induces an increase in initial tonus of the smooth muscles and simultaneously lowers the sensitivity of the smooth muscles to the action of the pharmacologically active substances mentioned.3. A similarity in the effect of different concentrations of KCl and different concentrations of F.D.P. on the contractile reaction of the guinea-pig intestine to constant doses of histamine and bradykinin and on the initial tonus of the smooth muscles is observed.4. A hypothesis is presented that F.D.P. in small doses potentiates the contractile action of amines and polypeptides on the smooth muscles and in larger doses increases the initial tonus of these muscles by changing the concentration of the cell electrolytes.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5762044      PMCID: PMC1703078          DOI: 10.1111/j.1476-5381.1969.tb07968.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Nature of peptides released by thrombin.

Authors:  J A GLADNER; P A MURTAUGH; J E FOLK; K LAKI
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  Smooth muscle as a contractile unit.

Authors:  A I CSAPO
Journal:  Physiol Rev Suppl       Date:  1962-07

3.  The relation of threshold to the K gradient in the myometrium.

Authors:  A CSAPO
Journal:  J Physiol       Date:  1956-07-27       Impact factor: 5.182

4.  The purification of human fibrinogen.

Authors:  R A KEKWICK; M E MACKAY; M H NANCE; B R RECORD
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

5.  Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs.

Authors:  R F FURCHGOTT; S BHADRAKOM
Journal:  J Pharmacol Exp Ther       Date:  1953-06       Impact factor: 4.030

6.  Unknown properties of the products of plasmin-degradation of fibrinogen and fibrin.

Authors:  K Buluk; M Malofiejew; M Czokalo
Journal:  Bull Acad Pol Sci Biol       Date:  1966

7.  Estimation of the activator of fibrinolysis by means of the euglobulin test.

Authors:  T Januszko; L Dubińska
Journal:  Acta Med Pol       Date:  1965

8.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

9.  Potentiation of bradykinin by a liver extract.

Authors:  D A Tewksbury; M A Stahmann
Journal:  Arch Biochem Biophys       Date:  1965-12       Impact factor: 4.013

10.  Fibrin degradation products in sera of normal subjects.

Authors:  P C Das; A G Allan; D G Woodfield; J D Cash
Journal:  Br Med J       Date:  1967-12-23
View more
  9 in total

1.  Inhibition of angiotensin I converting enzyme and kininase in rabbit plasma by bradykinin potentiating peptide B (Pyr-Gly-Leu-Pro-Arg-Pro-Lys-Ile-Pro-Pro).

Authors:  E Ueda; T Kokubu; H Akutsu; Y Yamamura
Journal:  Experientia       Date:  1971-09-15

2.  The influence of fibrinogen degradation products on the electrobiological activity of the rat heart.

Authors:  M Malofiejew; A Kostrzewska; K Buluk
Journal:  Experientia       Date:  1971-02-15

3.  Childhood bacterial meningitis.

Authors:  R H Lye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

4.  Dose-dependent nature of the interaction of fibrinogen-degradation products and 5-hydroxytryptamine on various vascular smooth muscle preparations [proceedings].

Authors:  C Forster; J Mohan; E T Whalley
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

5.  Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.

Authors:  Bihui Huang; Arun B Deora; Kai-Li He; Kang Chen; Guangzhi Sui; Andrew T Jacovina; Dena Almeida; Peng Hong; Paul Burgman; Katherine A Hajjar
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

6.  Biological effects of degradation products of collagen by bacterial collagenase.

Authors:  W Buczko; J Dziaczkowski; M Kopec; J Moniuszko-Jakoniuk; I Sopata; K Wisniewski; J Wize; E Wojtecka-Lukasik
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

7.  Vascular smooth muscle response to fibrinogen degradation products and 5-hydroxytryptamine: possible role in cerebral vasospasm in man.

Authors:  C Forster; E T Whalley; J Mohan; J Dutton
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

8.  Anti-inflammatory drugs modulate histamine release from mast cells induced by fibrinogen degradation products.

Authors:  E Wojtecka-Lukasik; J Stachurska; M Kopeć; S Maśliński
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

9.  Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation.

Authors:  H Fujisawa; H Ito; S Kashiwagi; S Nomura; M Toyosawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.